<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Sci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id><journal-title-group><journal-title>Scientific Reports</journal-title></journal-title-group><issn pub-type="epub">2045-2322</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7148328</article-id><article-id pub-id-type="publisher-id">63257</article-id><article-id pub-id-type="doi">10.1038/s41598-020-63257-4</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>A Two-Component regulatory system with opposite effects on glycopeptide antibiotic biosynthesis and resistance</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Alduina</surname><given-names>Rosa</given-names></name><address><email>valeria.alduina@unipa.it</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Tocchetti</surname><given-names>Arianna</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Costa</surname><given-names>Salvatore</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Ferraro</surname><given-names>Clelia</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Cancemi</surname><given-names>Patrizia</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Sosio</surname><given-names>Margherita</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Donadio</surname><given-names>Stefano</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1762 5517</institution-id><institution-id institution-id-type="GRID">grid.10776.37</institution-id><institution>Department of Biological, Chemical and Pharmaceutical Sciences and Technologies, </institution><institution>University of Palermo, Viale delle Scienze, </institution></institution-wrap>90128 Palermo, IT Italy </aff><aff id="Aff2"><label>2</label>Naicons Srl, Via Ortles 22/4, 20139 Milan, Italy </aff></contrib-group><pub-date pub-type="epub"><day>10</day><month>4</month><year>2020</year></pub-date><pub-date pub-type="pmc-release"><day>10</day><month>4</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>10</volume><elocation-id>6200</elocation-id><history><date date-type="received"><day>20</day><month>11</month><year>2019</year></date><date date-type="accepted"><day>3</day><month>3</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2020</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">The glycopeptide A40926, produced by the actinomycete <italic>Nonomuraea gerenzanensis</italic>, is the precursor of dalbavancin, a second-generation glycopeptide antibiotic approved for clinical use in the USA and Europe in 2014 and 2015, respectively. The final product of the biosynthetic pathway is an <italic>O-</italic>acetylated form of A40926 (acA40926). Glycopeptide biosynthesis in <italic>N. gerenzanensis</italic> is dependent upon the <italic>dbv</italic> gene cluster that encodes, in addition to the two essential positive regulators Dbv3 and Dbv4, the putative members of a two-component signal transduction system, specifically the response regulator Dbv6 and the sensor kinase Dbv22. The aim of this work was to assign a role to these two genes. Our results demonstrate that deletion of <italic>dbv22</italic> leads to an increased antibiotic production with a concomitant reduction in glycopeptide resistance. Deletion of <italic>dbv6</italic> results in a similar phenotype, although the effects are not as strong as in the &#x00394;<italic>dbv22</italic> mutant. Consistently, quantitative RT-PCR analysis showed that Dbv6 and Dbv22 negatively regulate the regulatory genes (<italic>dbv3</italic> and <italic>dbv4</italic>), as well as some <italic>dbv</italic> biosynthetic genes (<italic>dbv23</italic> and <italic>dbv24</italic>), whereas Dbv6 and Dbv22 positively regulate transcription of the single, cluster-associated resistance gene. Finally, we demonstrate that exogenously added acA40926 and its precursor A40926 can modulate transcription of <italic>dbv</italic> genes but with an opposite extent: A40926 strongly stimulates transcription of the Dbv6/Dbv22 target genes while acA40926 has a neutral or negative effect on transcription of those genes. We propose a model in which glycopeptide biosynthesis in <italic>N. gerenzanensis</italic> is modulated through a positive feedback by the biosynthetic precursor A40926 and a negative feedback by the final product acA40926. In addition to previously reported control systems, this sophisticated control loop might help the producing strain cope with the toxicity of its own product. This work, besides leading to improved glycopeptide producing strains, enlarges our knowledge on the regulation of glycopeptide biosynthesis in actinomycetes, setting <italic>N. gerenzanensis</italic> and its two-component system Dbv6-Dbv22 apart from other glycopeptide producers.</p></abstract><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Antimicrobials</kwd><kwd>Industrial microbiology</kwd><kwd>Microbial genetics</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2020</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par2">The glycopeptide antibiotic A40926 (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1A</xref>) is the precursor for dalbavancin (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1B</xref>), a semisynthetic lipoglycopeptide clinically used for treatment of acute skin infections caused by methicillin-susceptible and methicillin-resistant <italic>Staphylococcus aureus</italic> and <italic>Streptococcus pyogenes</italic>.<fig id="Fig1"><label>Figure 1</label><caption><p>Chemical structures of O-acetyl A40926 (<bold>A</bold>) and of dalbavancin (<bold>B</bold>) and genetic organization of the <italic>dbv</italic> cluster (<bold>C</bold>). (<bold>A,B</bold>). Only the component B0 (the major congener in the A40926 complex) is shown for simplicity. The acetyl group of A40926 and the chemical modification present in dalbavancin are indicated in red circle and pink, respectively. (<bold>C</bold>) The thin black arrows indicate experimentally determined operons. Red and green arrows represent the transcriptional units controlled by Dbv4 and Dbv3, respectively. The <italic>dbv</italic> genes are grouped by functional category as indicated. Asterisks indicate the genes analyzed by qRT-PCR analysis in the present work.</p></caption><graphic xlink:href="41598_2020_63257_Fig1_HTML" id="d29e339"/></fig></p><p id="Par3">A40926 is produced by the actinomycete <italic>N. gerenzanensis</italic> as a complex of related compounds, differing mostly by the type of <italic>N</italic>-acyl chain attached to the glucuronic acid moiety. The core structure of A40926 consists of a heptapeptide containing the proteinogenic amino acid tyrosine and the non-proteinogenic amino acids 3,5-dihydroxyphenylglycine (DPG) and 4-hydroxyphenylglycine (HPG). The heptapeptide is assembled by a nonribosomal peptide synthetase (NRPS) and modified by the action of various enzymes: four oxygenases, one halogenase, one hydroxylase, two glycosyltransferases, one hexose oxidase, one methyltransferase, one <italic>N-</italic>deacetylase, one <italic>N-</italic>acyltransferase and one <italic>O</italic>-acetyltransferase<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. The form with the acetylated mannose (acA40926) is considered the final biosynthetic product<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>. However, mild extraction conditions are necessary to isolate acA40926. While A40926 and acA40926 are equipotent in antibacterial activity against most strains, the former is slightly more active against <italic>S. aureus</italic> and <italic>Neisseria gonorrhoeae</italic><sup><xref ref-type="bibr" rid="CR3">3</xref></sup>. Hence, the desacetylated form has been used as the substrate for dalbavancin semi-synthesis. In addition, as many methods for complex analysis involve alkaline treatment of the culture, which results in hydrolysis of the ester bond, past literature considered A40926 as the main fermentation product. Detailed studies of the regulation of glycopeptide biosynthesis in <italic>N. gerenzanensis</italic> will be crucial for the development of rational approaches towards overproduction of the dalbavancin precursor. The <italic>dbv</italic> gene cluster for acA40926 biosynthesis contains 37 protein-coding sequences (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1C</xref>) that participate in antibiotic biosynthesis, regulation, immunity, and export<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR4">4</xref></sup>. Specifically, the cluster encodes the positive regulators Dbv3 and Dbv4 that indirectly or directly activate different operons leading to acA40926 biosynthesis<sup><xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR6">6</xref></sup>. Dbv3 and Dbv4 belong to the LAL (large ATP binding regulators of LuxR) and the StrR family of regulators, respectively. The cluster also contains the putative response regulator <italic>dbv6</italic> and the sensor-kinase <italic>dbv22</italic>, whose products may be part of a two-component system (TCS), even if the genes are not organized in a bicistronic operon<sup><xref ref-type="bibr" rid="CR4">4</xref>,<xref ref-type="bibr" rid="CR7">7</xref></sup>. A relevant characterized TCS in actinomycetes is the <italic>Streptomyces coelicolor</italic> VanR (VanR<sub>sc</sub>) and VanS (VanS<sub>sc</sub>) system associated with a glycopeptide resistance cassette in this species, which however does not produce any glycopeptide.</p><p id="Par4">In <italic>S. coelicolor</italic>, following vancomycin induction, the VanRSsc TCS activates transcription of the <italic>vanHAX</italic> genes, leading to the synthesis of peptidoglycan precursors terminating with D-alanyl&#x02013;D-lactate (DAla&#x02013;D-Lac), &#x000a0;causing a 1000-fold decreased binding affinity of vancomycin to its target<sup><xref ref-type="bibr" rid="CR8">8</xref>&#x02013;<xref ref-type="bibr" rid="CR11">11</xref></sup>. Thus, in its induction mechanism and in the resulting peptidoglycan modification, the mechanism leading to glycopeptide resistance in <italic>S. coelicolor</italic> resembles that used by pathogenic <italic>Enterococcus</italic> spp<sup><xref ref-type="bibr" rid="CR12">12</xref>,<xref ref-type="bibr" rid="CR13">13</xref></sup>. While some glycopeptide producers do contain a <italic>vanHAX</italic> cassette, either associated with the gene cluster<sup><xref ref-type="bibr" rid="CR14">14</xref>&#x02013;<xref ref-type="bibr" rid="CR16">16</xref></sup> or elsewhere in the genome<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>, the <italic>N. gerenzanensis</italic> genome does not contain any such genes<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>. <italic>N. gerenzanensis</italic> must thus use different strategy(ies) to cope with the self-toxicity of its own product. Marcone and coworkers showed that the wild type strain synthesizes a peptidoglycan with 3&#x02013;3 cross-linked peptide stems using the carboxypeptidase Dbv7<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>. Using substrates mimicking peptidoglycan, it was shown that Dbv7 cuts the D-Ala-D-Ala end of the peptidoglycan precursor on the outer surface of the cell membrane, mainly before and during antibiotic production<sup><xref ref-type="bibr" rid="CR19">19</xref>,<xref ref-type="bibr" rid="CR20">20</xref></sup>. However, deletion of <italic>dbv7</italic> in the original host or its heterologous expression result in measurable but modest differences in glycopeptide resistance<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>.</p><p id="Par5">In this study, we characterized the function of <italic>dbv6</italic> and <italic>dbv22</italic> with respect to glycopeptide biosynthesis and resistance in <italic>N. gerenzanensis</italic> and established that <italic>dbv</italic> biosynthesis genes are under negative control by this TCS, while the resistance gene <italic>dbv7</italic> is under positive control. In addition, we discovered that exogenously added A40926 and acA40926 differently affect transcription of selected <italic>dbv</italic> genes. Based on the current results and those reported previously<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>, a complex model of regulation can be depicted with the late pathway intermediate A40926 and the end product acA40926 having different roles in controlling antibiotic biosynthesis and resistance.</p></sec><sec id="Sec2" sec-type="results"><title>Results</title><sec id="Sec3"><title>Dbv6 and Dbv22 are transcriptional repressors of A40926 biosynthesis</title><p id="Par6"><italic>N. gerenzanensis</italic> mutants defective in <italic>dbv</italic>6 and <italic>dbv</italic>22 were constructed as previously reported<sup><xref ref-type="bibr" rid="CR6">6</xref></sup> and as described under Material and Methods, respectively. When <italic>N. gerenzanensis</italic> was grown in a rich medium (RARE3) that affords good growth but moderate glycopeptide production, disruption of <italic>dbv6</italic> or <italic>dbv22</italic> did not significantly affect biomass accumulation (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2A</xref>). Interestingly, bioassays (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2B</xref>) of culture broth collected along the growth showed that antibiotic production started at 54&#x02009;h in both mutants (12&#x02009;h earlier than in the parental strain) and proceeded to higher levels up to 96&#x02009;h, the last analyzed time point. Liquid chromatography&#x02013;mass spectrometry (LC-MS) analysis of 96-h culture broths showed that the &#x00394;<italic>dbv6</italic> and &#x00394;<italic>dbv22</italic> mutants produced 52 and 70&#x02009;&#x000b5;g/mL acA40926, respectively, in comparison with 34&#x02009;&#x000b5;g/mL, as observed with the parental strain.<fig id="Fig2"><label>Figure 2</label><caption><p>Growth curves and antibiotic production by <italic>N. gerenzanensis</italic> wild type, <italic>&#x00394;dbv6</italic> and <italic>&#x00394;dbv22</italic> strains in RARE3 medium. (<bold>A</bold>) The dry weight of the wild type, &#x00394;<italic>dbv</italic>6 and &#x00394;<italic>dbv</italic>22 strains are shown with green, red and blue lines, respectively. Standard deviation was calculated as average of three technical and two biological replicates. (<bold>B</bold>) Bioassays of 50&#x02009;&#x000b5;L of the culture broth of the wild type, &#x00394;<italic>dbv</italic>6 and &#x00394;<italic>dbv</italic>22 strains using <italic>K. rhizophila</italic> as test strain. (+) and (&#x02212;) indicate the positive (culture broth collected from the parental strain after 120&#x02009;h) and negative (only growth medium) control, respectively.</p></caption><graphic xlink:href="41598_2020_63257_Fig2_HTML" id="d29e600"/></fig></p><p id="Par7">When <italic>N. gerenzanensis</italic> was grown in a production medium (V40P), the higher production levels of the mutants were confirmed, with the &#x00394;<italic>dbv6</italic> and &#x00394;<italic>dbv22</italic> mutants producing 210 and 354&#x02009;&#x000b5;g/mL acA40926 after 7 days, respectively, in comparison with 130&#x02009;&#x000b5;g/mL seen in the parental strain (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). Interestingly, under these conditions, we observed a small but consistent decrease in biomass accumulation, which was inversely related to the amount of produced glycopeptide. There was no difference in complex composition between the mutants and the wild type (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S1</xref>), with acA40926 as the main product at all time points in the three strains.<fig id="Fig3"><label>Figure 3</label><caption><p>AcA40926 production and growth in V40P medium of the wild type, &#x00394;<italic>dbv6</italic> and <italic>&#x00394;dbv22</italic> strains. Squares indicate acA40926 concentrations, while triangles represent %PMV. Brown, red and violet symbols correspond to the wild type, &#x00394;<italic>dbv6</italic> and &#x00394;<italic>dbv22</italic> strains, respectively.</p></caption><graphic xlink:href="41598_2020_63257_Fig3_HTML" id="d29e639"/></fig></p><p id="Par8">These results demonstrate that Dbv6 and Dbv22 negatively regulate glycopeptide production and their abolition leads to increased antibiotic production, despite a small decrease in biomass, indicating a substantial higher productivity of the mutants (in terms of &#x000b5;g of product per unit of biomass) in comparison to the parental strain. Across two different media, deletion of <italic>dbv22</italic> has a more prominent effect than <italic>dbv6</italic>.</p><p id="Par9">Quantitative RT-PCR (qRT-PCR) analysis after 54&#x02009;h of growth in RARE3 medium of the wild type and the two mutants was carried out to identify the Dbv6/Dbv22 target genes within the <italic>dbv</italic> cluster (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>). We focused our attention on ten genes as representatives of all the <italic>dbv</italic> operons. Besides the regulators <italic>dbv3, dbv4</italic> and <italic>dbv6</italic>, the analysis was carried out on the biosynthetic genes <italic>dbv1</italic> and <italic>dbv5</italic> (HPG synthesis), <italic>dbv</italic>23 (mannose acetylation) and <italic>dbv15</italic> (MbtH-like protein assisting NRPS action), on the ABC-transporter genes <italic>dbv18</italic>, and <italic>dbv</italic>24, and on the resistance gene <italic>dbv7</italic><sup><xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR21">21</xref></sup> (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1C</xref>). Consistent with the results from bioassays and LC-MS analysis, qRT-PCR analysis showed that transcription of some analyzed genes was strongly influenced by deletion of <italic>dbv6</italic> and more so by <italic>dbv22</italic> genes (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>). Indeed, the transcriptional levels of <italic>dbv3, dbv4, dbv5, dbv23</italic> and <italic>dbv24</italic> increased approximately 2&#x02013;5 fold in the <italic>&#x00394;dbv6</italic> mutant and 5&#x02013;20 fold in the &#x00394;<italic>dbv22</italic> mutant; in contrast, <italic>dbv7</italic> was apparently not transcribed in both mutants. The transcriptional levels of <italic>dbv1, dbv6</italic>, and <italic>dbv18</italic> were not influenced by either mutation (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>).<fig id="Fig4"><label>Figure 4</label><caption><p>qRT-PCR of <italic>dbv</italic> genes in the wild type and <italic>&#x00394;dbv6</italic> and <italic>&#x00394;dbv22</italic> mutant strains. For each gene, data are normalized to the parental strain (blue bars). Red and green bars represent relative RNA levels seen in the &#x00394;<italic>dbv6</italic> and &#x00394;<italic>dbv22</italic> strains, respectively. Error bars are calculated from three independent determinations of mRNA abundance in each sample. RNAs were extracted after 54&#x02009;h of growth in RARE3 medium.</p></caption><graphic xlink:href="41598_2020_63257_Fig4_HTML" id="d29e755"/></fig></p></sec><sec id="Sec4"><title>Dbv22 enhances glycopeptide resistance</title><p id="Par10">We tested the wild type and the two mutant strains for sensitivity to A40926 and acA40926. Consistent with previous results<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>, the wild type strain formed no visible colonies when plated on medium containing 4&#x02009;&#x000b5;g/mL A40926. Remarkably, it was more sensitive to acA40926 than to its desacetylated precursor, with a significant reduction in the ability to form colonies observed already at 0.5&#x02013;1&#x02009;&#x000b5;g/mL (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>). No significant differences between the wild type and the &#x00394;<italic>dbv6</italic> mutant were observed. In contrast, the <italic>&#x00394;dbv22</italic> mutant strain was more sensitive to acA40926 and A40926, and it was able to form visible colonies only with up to 0.5 and 0.2&#x02009;&#x000b5;g/mL of A40926 and acA40926, respectively (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>). Thus, consistent with qRT-PCR analysis, Dbv22 positively controls resistance to glycopeptides, likely by regulating expression of the carboxypeptidase Dbv7. The lack of an effect on glycopeptide resistance by the <italic>dbv6</italic> deletion might be due to the narrow range of glycopeptide concentration in which an effect is seen.<fig id="Fig5"><label>Figure 5</label><caption><p>Resistance assay of the wild type and <italic>&#x00394;dbv6</italic> and <italic>&#x00394;dbv22</italic> mutant strains. Plating efficiency of the wild type, &#x00394;<italic>dbv6</italic> and &#x00394;<italic>dbv22</italic> strains on different concentrations of A40926 (solid lines) or of acA40926 (dashed lines). Reported data are the average of two independent counts. The limit of detection were 10<sup>5</sup> CFU/mL for the wild type, &#x00394;<italic>dbv6</italic>, and &#x00394;<italic>dbv22</italic>&#x000a0;strains.</p></caption><graphic xlink:href="41598_2020_63257_Fig5_HTML" id="d29e811"/></fig></p></sec><sec id="Sec5"><title>A40926 strongly induces expression of <italic>dbv</italic> genes</title><p id="Par11">The above results indicate that <italic>N. gerenzanensis</italic> can discriminate, in terms of sensitivity, between the highly related glycopeptides A40926 and acA40926. Previous work had also indicated that exogenously added acA40926, but not its desacetylated form, had an inhibitory effect on glycopeptide production<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>. We thus wondered whether exogenously added glycopeptides would have any effect on the transcriptional levels of the Dbv6/Dbv22 target genes. To this end, a 24&#x02009;h culture of the parental strain inV40P medium was equally divided into three flasks, with each flask receiving either 0.5&#x02009;&#x000b5;g/mL A40926, 0.5&#x02009;&#x000b5;g/mL acA40926 or no addition. After further 2- and 5-h incubation, RNA was extracted and the transcriptional levels of all the regulatory genes (<italic>dbv3, dbv4</italic> and <italic>dbv6</italic>) and of the Dbv6-targeted genes (<italic>dbv7</italic>, <italic>dbv23</italic> and <italic>dbv24</italic>) were analyzed by qRT-PCR (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>). Addition of acA40926 had a modest inducing effect on the expression of the regulatory genes <italic>dbv4</italic> and <italic>dbv6</italic>, the resistance gene <italic>dbv7</italic> and the acetyltransferase gene <italic>dbv23</italic>, but only 2&#x02009;h after compound addition. After 5&#x02009;h, genes were slightly repressed (<italic>dbv3</italic>, <italic>dbv4</italic>, <italic>dbv6</italic> and <italic>dbv7</italic>) or unaffected (<italic>dbv23</italic> and <italic>dbv24</italic>). In contrast, addition of A40926 did not significantly affect transcription levels after 2&#x02009;h. However, after 5&#x02009;h all the analyzed genes were induced, with transcription levels 2-fold (for <italic>dbv3</italic>), 3&#x02013;6-fold (for <italic>dbv4</italic>, <italic>dbv6</italic> and <italic>dbv7</italic>) or 13&#x02013;14-fold (for <italic>dbv23</italic> and <italic>dbv24</italic>) higher relative to uninduced cells. qRT-PCR of the analyzed <italic>dbv</italic> genes in all three cultures before induction indicated modest flask-to-flask variation (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S2</xref>).<fig id="Fig6"><label>Figure 6</label><caption><p>qRT-PCR analysis of the gene expression of <italic>dbv3, dbv4, dbv6</italic>, <italic>dbv7, dbv23</italic> and <italic>dbv24</italic> in the wild type strain. RNA was isolated from the wild type strain incubated in V40P medium for 2 and 5&#x02009;h in the presence of 0.5&#x02009;&#x000b5;g/mL A40926 (black bars) or 0.5&#x02009;&#x000b5;g/mL acA40926 (red bars). Data are expressed as relative values to the no-addition controls. Within each sample, mRNA levels were normalized to <italic>hrdB</italic>, arbitrarily setting the ratio for each sample to 1. Standard deviations are calculated from three independent determinations of mRNA abundance in each sample.</p></caption><graphic xlink:href="41598_2020_63257_Fig6_HTML" id="d29e923"/></fig></p><p id="Par12">The above experiments were performed using the wild type strain, which does produce acA40926 and related pathway intermediates, with exogenous compounds added during early exponential growth, when glycopeptide levels are below the limit of detection (about 1&#x02009;&#x000b5;g/mL). When a similar experiment was carried out with the &#x00394;<italic>dbv4</italic> mutant strain, which does not produce any glycopeptide<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>, we could not detect any transcription of <italic>dbv23</italic> and <italic>dbv24</italic>, suggesting that these genes might be indirect targets of Dbv4 (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S3</xref>). Thus, one or more components of the glycopeptide complex or intermediates thereof could exert a positive feedback on the transcription of at least some <italic>dbv</italic> genes.</p></sec><sec id="Sec6"><title>Direct control of Dbv6 on <italic>dbv4</italic> and <italic>dbv7</italic> gene expression</title><p id="Par13">We investigated whether Dbv6 can bind to the upstream region of the target genes and directly control their expression. Gel mobility shift assays of the regions upstream to <italic>dbv3, dbv4, dbv6, dbv7, dbv23</italic> and <italic>dbv24</italic> were carried out using a purified His-tagged Dbv6 protein overexpressed in <italic>E. coli</italic>. These assays did reveal a binding activity of Dbv6 towards the upstream regions of the regulatory genes <italic>dbv3</italic> and <italic>dbv4</italic>, of the resistance gene <italic>dbv7</italic>, of the genes <italic>dbv23-dbv22</italic>, coding for the acetyltransferase and the sensor kinase, and of the operon <italic>dbv24-dbv28</italic>, which encodes an ABC-transporter, two NRPS modules, the <italic>N-</italic>methyltransferase and the enzyme involved in &#x003b2;-hydroxylation of the tyrosine residue (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>). No shift was detected using the upstream region of <italic>dbv6</italic> (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>). Control experiments using the internal region of the vegetative sigma factor encoding gene (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S4</xref>) further confirmed the specificity of DNA binding by Dbv6 observed on some of the target genes. Thus, these data are consistent with Dbv6 directly controlling expression of the target genes. Further studies will be necessary to understand how Dbv6 exerts positive and negative control on different DNA regions.<fig id="Fig7"><label>Figure 7</label><caption><p>Gel mobility shift assays of DNA regions upstream of <italic>dbv</italic>3, <italic>dbv</italic>4, <italic>dbv7</italic>, <italic>dbv23, dbv24</italic> and <italic>dbv6</italic>. Lanes labeled with an asterisk contained the probe only (up<italic>dbv3</italic>, up<italic>dbv4</italic>, up<italic>dbv7</italic>, up<italic>dbv23</italic>, up<italic>dbv24</italic> and up<italic>dbv6</italic>). All lanes contained 50&#x02009;ng of target DNA. Increasing concentrations of His-Dbv6 (0.5, 1, 1.5, 2&#x02009;mM) were incubated in the presence of probes as indicated.</p></caption><graphic xlink:href="41598_2020_63257_Fig7_HTML" id="d29e1040"/></fig></p></sec><sec id="Sec7"><title>Dbv6 and Dbv22 are unrelated to other TCSs associated with other glycopeptide gene clusters</title><p id="Par14">TCSs are often associated with glycopeptide gene clusters, where they have been shown in some cases to play a role in glycopeptide resistance. They appear similar to the well-characterized <italic>S. coelicolor</italic> VanRS system, which plays a role in glycopeptide resistance in a non-producing strain<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>. However, reciprocal Blast searches indicate that Dbv6 and Dbv22 are not orthologs of VanR<sub>sc</sub> and VanS<sub>sc</sub>, respectively. Inspired by recent work on phylogenetic analysis of cluster-associated StrR- and LuxR-related regulators<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>, we performed a phylogenetic analysis of TCSs from actinomycetes. To this end, we retrieved response regulators and sensory kinases associated with characterized actinobacterial gene clusters from the MiBIG database<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>, well-characterized TCSs from <italic>Streptomyces coelicolor</italic><sup><xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR25">25</xref></sup> and the response regulators and sensory kinases identified in the <italic>N. gerenzanensis</italic> genome<sup><xref ref-type="bibr" rid="CR18">18</xref></sup> (Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8</xref>).<fig id="Fig8"><label>Figure 8</label><caption><p>Phylogenetic analysis of 62 response regulators (left panel) and 65 sensory kinases (right panel). Sequences associated with established gene clusters are identified by the compound name followed by the genus of the corresponding strain; characterized <italic>S. coelicolor</italic> proteins are identified by the protein name followed by the SCO code; and <italic>N. gerenzanensis</italic> sequences are denoted by the SBO or SBP codes. The branches associated with the Van-and Dbv-related TCSs are identified by green and orange boxes, respectively. Green and red arrows indicate the adjacent members of two different, uncharacterized <italic>N. gerenzanensis</italic> TCSs closely associated with the Dbv branches. Sequences associated with <italic>N. gerenzanensis</italic> biosynthetic gene clusters, as identified by AntiSMASH 5.0<sup><xref ref-type="bibr" rid="CR42">42</xref></sup>, have a yellow highlight.</p></caption><graphic xlink:href="41598_2020_63257_Fig8_HTML" id="d29e1112"/></fig></p><p id="Par15">With respect to the response regulators, those associated with the balhimycin, teicoplanin and A47934 clusters branch together along with <italic>S. coelicolor</italic> VanR (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>, left panel). In contrast, Dbv6 clusters together with response regulators associated with gene clusters for kistamicin A (from a <italic>Nonomuraea</italic> sp<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>) and for feglymycin (from a <italic>Streptomyces</italic> sp<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>.). Kistamicin A is a partially cross-linked heptapeptide sharing some amino acid residues with glycopeptide antibiotics, whereas feglymycin is a linear tridecapeptide containing several HPG and DPG residues. Both compounds have antiviral activity but modest antibacterial activity in comparison with glycopeptide antibiotics<sup><xref ref-type="bibr" rid="CR28">28</xref>&#x02013;<xref ref-type="bibr" rid="CR30">30</xref></sup>.</p><p id="Par16">A similar picture emerges when analyzing the sensory kinases: those associated with the balhimycin, teicoplanin and A47934 clusters, and <italic>S. coelicolor</italic> VanS form a separate branch from the one containing Dbv22 and the kistamicin A- and flegymycin-associated sequences (Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8</xref>, right panel). Interestingly, the adjacent members of two different, uncharacterized TCSs encoded by the <italic>N. gerenzanensis</italic> genome cluster closely with the Dbv6 and Dbv22 branches, suggesting these proteins might respond to similar stimuli and/or be regulated by similar factors. It should be noted that all the other sensory kinases or response regulators from <italic>N. gerenzanensis</italic> associated to a putative biosynthetic gene cluster are unrelated to Dbv6 or Dbv22.</p></sec></sec><sec id="Sec8" sec-type="discussion"><title>Discussion</title><p id="Par17">The results presented here provide evidence that the response regulator Dbv6 and the sensor kinase Dbv22 negatively control A40926 production and that Dbv22 positively controls A40926 resistance. These effects are associated with altered transcription levels. Indeed, strains deleted for these genes are upregulated in the expression of the two key regulators <italic>dbv3</italic> and <italic>dbv4</italic>. Conversely, the <italic>&#x00394;dbv22</italic> mutant strain expresses less <italic>dbv7</italic>, the only resistance gene present in the <italic>dbv</italic> cluster. This would suggest that Dbv6 and Dbv22 represent the two components of a signal transduction system responding to some stimuli and controlling key elements of the <italic>dbv</italic> cluster. Remarkably, deletion of <italic>dbv22</italic> can lead to the paradoxical result of a mutant producing increased glycopeptide levels while becoming more sensitive to its own product.</p><p id="Par18">While TCSs are frequently found in glycopeptide gene clusters, different regulatory strategies are apparently adopted by glycopeptide-producing actinomycetes. Abolition of the response regulator or of the sensor kinase gene in <italic>Streptomyces toyocaensis</italic> led to increased sensitivity to A47934<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>. In <italic>Amycolatopsis balhimycina</italic>, the deletion of genes for the VanRS-like TCS VnlRSAb affected VanY expression in a &#x00394;<italic>van</italic>HAX background<sup><xref ref-type="bibr" rid="CR31">31</xref></sup> while did not influence balhimycin production<sup><xref ref-type="bibr" rid="CR17">17</xref>,<xref ref-type="bibr" rid="CR31">31</xref></sup>. In the glycopeptide non-producing <italic>S. coelicolor</italic>, deletion of <italic>vanR</italic> but not of <italic>vanS</italic> led to a strain sensitive to vancomycin<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>. Apart from the VanR genes associated with a <italic>vanHAX</italic> resistance cassette (e.g, those from <italic>S. coelicolor</italic>, <italic>S. toyocaensis</italic> and <italic>Actinoplanes teichomyceticus</italic>), the gene(s) targeted by VanR in <italic>A. balhimycina</italic> remain to be identified. Here, we demonstrate that in <italic>N. gerenzanensis</italic> direct target genes of Dbv6 are the regulatory genes <italic>dbv3</italic> and <italic>dbv4</italic>, and the genes <italic>dbv23-dbv22</italic>, coding for the acetyltransferase and the sensor kinase, and the <italic>dbv24-dbv28</italic> operon, since the transcription of all these genes is induced in the <italic>&#x00394;</italic><italic>dbv6</italic> mutant background and that Dbv6 binds to the upstream regions of these genes. Another direct target of Dbv6 but regulated in the opposite manner is the peptidase <italic>dbv7</italic> (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>).</p><p id="Par19">The impacts of the <italic>dbv6</italic> and <italic>dbv22</italic> mutations are quantitatively different. First of all, the relative expression levels of the analyzed <italic>dbv</italic> genes (encoding the positive regulators Dbv3 and Dbv4, the prephenate dehydrogenase Dbv5, the acetyltransferase Dbv23 and the ABC-transported Dbv24) in the <italic>&#x00394;dbv6</italic> mutant are somehow intermediate between those of the parental strain and of the <italic>&#x00394;dbv22</italic> mutant (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>). In terms of antibiotic resistance, the <italic>&#x00394;dbv22</italic> strain is marginally but consistently more sensitive than the parental strain and the <italic>&#x00394;dbv6</italic> mutant to A40926 and acA40926. Finally, when <italic>N. gerenzanensis</italic> is grown in production medium, the <italic>&#x00394;dbv6</italic> and the <italic>&#x00394;dbv22</italic> mutants show, up to 48&#x02009;h, an identical but slightly higher acA40926 production rate than the parental strain, with <italic>&#x00394;dbv22</italic> keeping an equivalent rate up to 7 days and reaching acA40926 levels (350&#x02009;&#x000b5;g/mL) significantly higher than <italic>&#x00394;dbv6</italic> and the parental strain (200 and 130&#x02009;&#x000b5;g/mL, respectively; Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). Remarkably, higher production levels by <italic>&#x00394;dbv22</italic> are achieved despite a slightly lower biomass accumulation (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>).</p><p id="Par20">The fact that all the analyzed parameters are more strongly altered in the <italic>&#x00394;dbv22</italic> than in the <italic>&#x00394;dbv6</italic> background suggests that Dbv22 and/or Dbv6 might interact with other response regulators and/or sensor kinases, respectively, present in the cell. Indeed, the <italic>N. gerenzanensis</italic> genome harbors 43 and 47 TCS pairs, some of them highly related to VanR and VanS (Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8</xref>). A homologous of <italic>dbv6</italic> gene is present in the <italic>N. gerenzanensis</italic> genome. The gene is located about 4.5 Mbp away from Dbv6, with which it shows 68% sequence identity and 77% similarity. All 8 diagnostic residues of the phosphorylation site are invariant with Dbv6. The HTH domain is highly conserved.</p><p id="Par21">Marcone and coworkers<sup><xref ref-type="bibr" rid="CR19">19</xref></sup> have previously shown that <italic>N. gerenzanensis</italic> is essentially sensitive to A40926, that the carboxypeptidase VanY (i.e., Dbv7) provides some protection but that insensitivity to glycopeptides is mostly acquired during growth by some unknown mechanism. That some other resistance mechanism operates in <italic>N. gerenzanensis</italic> is consistent with our observed lack of transcription of <italic>dbv7</italic> in the <italic>&#x00394;dbv6</italic> strain (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>), a mutant that is as glycopeptide resistant as the parental strain (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>). Thus, <italic>dbv6</italic> does not apparently contribute to glycopeptide resistance while <italic>dbv22</italic> does, suggesting that a second resistance mechanism influenced by Dbv22 takes over. The complex interplay of glycopeptide production and resistance is also highlighted by the fact that deletion of <italic>dbv7</italic> did not affect A40926 production, as reported by Marcone and coworkers<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>.</p><p id="Par22">When added just at 24&#x02009;h of growth, when no glycopeptide production is detected yet, 0.5&#x02009;&#x000b5;g/mL A40926 can strongly induce expression of all tested <italic>dbv</italic> genes, particularly <italic>dbv23</italic> and <italic>dbv24</italic>. AcA40926 has the opposite effect. The simplest explanation of this observation is that A40926, but not acA40926, binds to a receptor to activate signal transduction, relieving inhibition or leading to a massive transcription of <italic>dbv</italic> genes. It is tempting to speculate that the receptor that A40926 binds to is actually Dbv22. Indeed, the ~14-fold stimulation of <italic>dbv24</italic> upon A40926 addition is remarkably similar to its upregulated expression in the &#x00394;<italic>dbv22</italic> background. Sensor kinases have been shown to be able to recognize and respond to glycopeptides: VanS<sub>sc</sub> is induced by vancomycin but not by teicoplanin and A47934<sup><xref ref-type="bibr" rid="CR8">8</xref>,<xref ref-type="bibr" rid="CR11">11</xref></sup>, while the <italic>S. toyocaensis</italic> VanS sensor kinase is induced by A47934 but not by vancomycin and teicoplanin<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>.</p><p id="Par23">In earlier work, we showed that a strain defective in mannose acetylation produces increased levels of A40926 in comparison to the wild type and that this enhanced production can be reverted by adding acA40926 &#x02013; but not A40926 &#x02013; to the culture at time zero, while addition of acA40926 had no effect on the wild type<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>. The present and previous results are consistent assuming that acA40926 can also bind to the same receptor but it cannot trigger its activation. Thus, acA40926 would compete with A40926 for the same binding site, acting as an apparent inhibitor of glycopeptide production. Discrimination between the acetylated and desacetylated form of the glycopeptide by <italic>N. gerenzanensis</italic> can also be observed in the resistance profile of the wild type, which is more sensitive to acA40926 than A40926 (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>).</p><p id="Par24">The data presented here and in previous work<sup><xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR6">6</xref></sup> allow us to refine a possible model for regulation of glycopeptide production in <italic>N. gerenzanensis</italic><sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. When cells are actively growing, transcription of <italic>dbv3</italic> and <italic>dbv4</italic> is repressed by the direct action of Dbv6, as well as by other factors related to growth (nutritional factors, or quorum sensing systems could control A40926 biosynthesis)<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. At the same time, the resistance gene <italic>dbv7</italic> is expressed as a safeguard mechanism against small amounts of glycopeptides that might be produced. As growth slows down, expression of the master regulators Dbv3 and Dbv4 increases so that some glycopeptide synthesis can occur. When sufficient A40926 accumulates, repression mediated by Dbv6/Dbv22 is relieved and further expression of the <italic>dbv</italic> genes can occur, including that of the acetyltransferase <italic>dbv23</italic> and of the ABC transporter <italic>dbv24</italic>, which results in formation of acA40926 form and its export outside of the cell, where it can compete out A40926 for Dbv22 binding, eventually restoring repression exerted by Dbv6/Dbv22.</p><p id="Par25">This mechanism is somehow reminiscent of the feed forward mechanism proposed for microbisporicin/NAI-107 production in <italic>Microbispora corallina</italic>, where a late pathway intermediate can activate production<sup><xref ref-type="bibr" rid="CR32">32</xref></sup> through the activation of the ECF sigma factor &#x003c3;MibX, sequestered at the membrane level by an antisigma factor. An unknown signal should lead to production of microbisporicin, the inactivation of the anti-sigma factor, the release of &#x003c3;<sup>MibX</sup>, and high-level expression of the entire gene cluster. Interestingly, both A40926 and NAI-107 target lipid II<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>, are produced by two strains belonging to different genera of the order <italic>Streptosporangiales</italic> that contain 3&#x02013;3 cross-linked dimers in their cell wall and that are highly sensitive to their own product<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>.</p></sec><sec id="Sec9" sec-type="materials|methods"><title>Material and methods</title><sec id="Sec10"><title>Bacterial strains and culture conditions</title><p id="Par26">The bacterial strains and plasmids used in this study are listed in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>. <italic>Escherichia coli</italic> strains were grown in Luria broth liquid medium at 37&#x02009;&#x000b0;C and supplemented with 50&#x02009;&#x000b5;g/mL apramycin when necessary to maintain plasmids.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Bacterial strains, plasmids and cosmids used in this study.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Strain or plasmid</th><th>Description</th><th>Source or reference</th></tr></thead><tbody><tr><td colspan="3"><bold>Bacterial strains</bold></td></tr><tr><td><italic>Nonomuraea gerenzanensis</italic></td><td>Wild type</td><td>ATCC&#x000a0;39727</td></tr><tr><td><italic>&#x00394;dbv6</italic> mutant</td><td><italic>N. gerenzanensis</italic> strain in which the <italic>dbv6</italic> gene was replaced with an apramycin cassette</td><td><sup><xref ref-type="bibr" rid="CR6">6</xref></sup></td></tr><tr><td><italic>&#x00394;dbv22</italic> mutant</td><td><italic>N. gerenzanensis</italic> strain in which the <italic>dbv22</italic> gene was replaced with an apramycin cassette</td><td>This study</td></tr><tr><td><italic>Kocuria rhizophila</italic></td><td>Used for bioassay of A40926</td><td>ATCC&#x000a0;9341</td></tr><tr><td><italic>Escherichia coli</italic> DH10B</td><td>F_ <italic>endA1 recA1 galE15 galK16 nupG rpsL</italic> &#x00394;<italic>lacX74</italic> &#x00394;80<italic>lacZ</italic>&#x00394;M15 <italic>araD139</italic> &#x00394;(<italic>ara-leu</italic>)<italic>7697 mcrA</italic> &#x00394;(<italic>mrr-hsdRMS-mcrBC</italic>) &#x003bb;<sup>-</sup>; host for routine subcloning experiments</td><td>Invitrogen</td></tr><tr><td><italic>Escherichia coli</italic> ET12567/pUZ8002</td><td>(<italic>dam-13</italic>::Tn<italic>9 dcm-6</italic>) pUZ8002<sup>+</sup>(&#x00394;<italic>oriT</italic>); used for conjugative transfer of DNA and for demethylating plasmid DNA</td><td><sup><xref ref-type="bibr" rid="CR44">44</xref></sup></td></tr><tr><td><italic>Escherichia coli</italic> BW25113/pIJ790</td><td>&#x00394; (<italic>araD-araB</italic>)567 &#x00394;<italic>lacZ4787</italic> (::<italic>rrnB-4</italic>) <italic>lacIp-4000</italic> (<italic>lacI</italic>q) &#x003bb;<sup>-</sup>
<italic>rpoS369</italic> (Am) <italic>rph-1</italic> &#x00394; (<italic>rhaD-rhaB</italic>) <italic>568 hsdR514</italic>: used to generate recombinant cosmid 1B1</td><td><sup><xref ref-type="bibr" rid="CR45">45</xref></sup></td></tr><tr><td colspan="3"><bold>Plasmid/cosmid</bold></td></tr><tr><td>1B1</td><td>Cosmid containing part of the <italic>dbv</italic> cluster from <italic>dbv</italic>17 to <italic>dbv</italic>37</td><td><sup><xref ref-type="bibr" rid="CR4">4</xref></sup></td></tr><tr><td>1B1&#x00394;<italic>dbv22</italic></td><td>Derivative of 1B1 with the inactivated <italic>dbv</italic>22 gene</td><td>This study</td></tr><tr><td>pIJ773</td><td>pUC19 containing the <italic>aac(3)IV-oriT</italic> cassette; source of the <italic>aac(3)</italic> gene</td><td><sup><xref ref-type="bibr" rid="CR37">37</xref></sup></td></tr></tbody></table></table-wrap></p><p id="Par27">Cell stocks of the <italic>N. gerenzanensis</italic> strains were prepared from cultures in RARE3 medium as already described<sup><xref ref-type="bibr" rid="CR34">34</xref></sup> and stored at &#x02212;80&#x02009;&#x000b0;C. Liquid cultures were prepared by inoculating 0.2&#x02009;mL of the frozen stock into 20&#x02009;mL of RARE3 medium; after 120&#x02009;h of growth, 1&#x02009;mL of this culture was inoculated into 50&#x02009;mL of fresh RARE3 medium in an orbital shaker (500 &#x000d7; g) in 250-mL baffled flasks at 30&#x02009;&#x000b0;C. To detect glycopeptide production, samples of culture broths at different time points were withdrawn and stored at &#x02212;80&#x02009;&#x000b0;C before analysis. Cultivation in glycopeptide production medium was performed as already described<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>. Biomass was determined by measuring the cell dry weight of mycelial pellet recovered from a 1-mL culture sample after drying the pellet at 65&#x02009;&#x000b0;C for about 24&#x02009;h. Alternatively, the relative packed mycelial volume (%PMV) was determined after centrifugation of a 6-mL culture sample for 10&#x02009;min at 4000 &#x000d7; g.</p><p id="Par28">For assessing induction by glycopeptides, the parental strain or the <italic>&#x00394;dbv4</italic> mutant were cultivated in V40S medium as above and then transferred into (fresh) V40P medium<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>. After 24&#x02009;h at 30&#x02009;&#x000b0;C, the culture was equally divided into three flasks, and either 0.5&#x02009;&#x000b5;g/mL A40926 or 0.5&#x02009;&#x000b5;g/mL acA40926 were added, with the third flask used as no-addition control. After further 2 and 5&#x02009;h, 1-mL samples were collected and centrifuged to recover cells. RNA was extracted and processed as below.</p></sec><sec id="Sec11"><title>Analysis of antibiotic production</title><p id="Par29">Antibiotic production of the mutant strains was firstly evaluated using the paper disc diffusion method and <italic>Kocuria rhizophila</italic> as the assay organism as described previously<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>. For high-performance liquid chromatography (HPLC) and liquid chromatography-mass spectrometry (LC-MS) analyses, 500&#x02009;&#x000b5;L aliquots of broth cultures were collected at the time points indicated and treated as reported previously<sup><xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR36">36</xref></sup>.</p></sec><sec id="Sec12"><title>Construction of the &#x00394;dbv22 strain</title><p id="Par30">PCR targeting<sup><xref ref-type="bibr" rid="CR37">37</xref></sup> was applied to replace <italic>dbv22</italic> with a cassette containing an apramycin-selectable marker using pIJ773 as template and the PCR primers reported in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>. <italic>E. coli BW25113/pIJ790</italic> bearing cosmid 1B1<sup><xref ref-type="bibr" rid="CR4">4</xref></sup> was electrotransformed with the deletion cassette. Intergeneric conjugation was carried out as previously reported<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>. Exconjugants were analyzed by PCR (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S5</xref>) using primers reported in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>. One out of eleven clones analyzed contained the interrupted <italic>dbv22</italic> gene and used for further studies. Sequencing of the PCR product confirmed that the apramycin-resistant cassette was correctly inserted in the target gene through homologous double-cross recombination.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Primers used in this study.</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Gene(s)</th><th>Forward (5&#x02032;-3&#x02032;)</th><th>Reverse (5&#x02032;-3&#x02032;)</th><th>Predicted size (bp)</th></tr></thead><tbody><tr><td colspan="4"><bold>Used in RT-PCR or qRT-PCR</bold></td></tr><tr><td><italic>hrdb</italic></td><td>ctgatcaacaaggtcgcccg</td><td>gccgtacctctgcacctcg</td><td>129</td></tr><tr><td><italic>16S</italic></td><td>agcttgttggtggggtagtg</td><td>tcaccgctacaccaggaatt</td><td>470</td></tr><tr><td><italic>dbv3</italic></td><td>gaagaggttgcccaggtcac</td><td>ccgaggcgctctacatcac</td><td>101</td></tr><tr><td><italic>dbv4</italic></td><td>cagtaattccggcttggtcc</td><td>aaacaggtcggcatctccc</td><td>114</td></tr><tr><td><italic>dbv5</italic></td><td>gtggacctggcattgatcg</td><td>ctggtcacatcggtgtacgc</td><td>101</td></tr><tr><td><italic>dbv6</italic></td><td>agctgtgcgctgagatcg</td><td>acggcttcggcagatagtc</td><td>126</td></tr><tr><td><italic>dbv7</italic></td><td>ccagctcgtcggtctcac</td><td>cccttgacgtggttggac</td><td>141</td></tr><tr><td><italic>dbv23</italic></td><td>gaccgcccacttgttgatc</td><td>ggcagctcaccacctacg</td><td>110</td></tr><tr><td><italic>dbv24</italic></td><td>tcggaggtttgctgaagg</td><td>agatcgaatccaatgcgg</td><td>147</td></tr><tr><td colspan="4"><bold>Used to prepare probes for EMSA</bold></td></tr><tr><td><italic>upstream 3</italic></td><td>gaatcgagcaacctcgtcag</td><td>gcaggaatgggaaaggatct</td><td>300</td></tr><tr><td><italic>upstream 4</italic></td><td>gcatcggtcttatccgaaac</td><td>cgtcgcatcctcttttcttc</td><td>226</td></tr><tr><td><italic>upstream 6</italic></td><td>tggtcgaggtctccgtgc</td><td>cattcgtgtcgccgtctc</td><td>150</td></tr><tr><td><italic>upstream 7</italic></td><td>tgaaggcgacgatcaacc</td><td>tcctcatccctctcctccag</td><td>188</td></tr><tr><td><italic>upstream 23</italic></td><td>gtccaggtgaacgcttggt</td><td>ccttcagcaaacctccgaac</td><td>178</td></tr><tr><td><italic>upstream 24</italic></td><td>gcaggtcggaagggacatc</td><td>gtgaccaagcgttcacctgg</td><td>176</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec13"><title>Resistance assay</title><p id="Par31">The ability to form colonies of the <italic>N. gerenzanensis</italic> wild type, <italic>&#x00394;dbv6</italic> and <italic>&#x00394;dbv22</italic> strains was assessed by plating serial dilutions of stock cultures (prepared from frozen mycelium) on 0.25X BTT plates<sup><xref ref-type="bibr" rid="CR38">38</xref></sup> containing 0, 0.1, 0.2, 0.5, 1.0, 2.0 or 4.0&#x02009;&#x000b5;g/mL A40926 or acA40926. Two replicate plates were used for each antibiotic concentration. After 6 days at 30&#x02009;&#x000b0;C, the number of colony forming units (CFU) was recorded.</p></sec><sec id="Sec14"><title>Total RNA isolation and qRT-PCR analysis</title><p id="Par32">To perform transcriptional analysis, a 6-mL sample was withdrawn from a 30-mL culture. The mycelium was harvested by centrifugation and RNA was extracted using the RNeasy midi kit (Qiagen), followed by treatment with DNase I (Roche) according to the manufacturer&#x02019;s instructions. RNA quality was previously checked using Reverse transcription (RT)-PCR analysis as previously described<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>. It was converted to cDNA as already described<sup><xref ref-type="bibr" rid="CR34">34</xref></sup> and amplified using primers reported in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>. As control genes, <italic>hrdB</italic>, encoding a vegetative sigma factor, or 16S rRNA, were used. Gene expression was analyzed quantitatively by using the 7300 real-time PCR system (Applied Biosystems) with SYBR green PCR master mix (Applied Biosystems) in 96-well plates. Two microliters of cDNA was added to 20&#x02009;&#x000b5;L of the PCR mixture. Amplification required activation of AmpErase UNG at 50&#x02009;&#x000b0;C for 2&#x02009;min, followed by denaturation at 95&#x02009;&#x000b0;C for 10&#x02009;min and then 40 cycles at 95&#x02009;&#x000b0;C for 15&#x02009;s and 60&#x02009;&#x000b0;C for 1&#x02009;min.</p></sec><sec id="Sec15"><title>Overexpression and purification of recombinant protein His-Dbv6</title><p id="Par33"><italic>Escherichia coli</italic> DH10B and BL21 (Invitrogen) were used in this study. Plasmids pGEM-T (Promega) and pRSETB (Invitrogen) were used for cloning PCR products, and protein expression, respectively. <italic>N. gerenzanensis</italic> chromosomal DNA was used as template to amplify <italic>dbv</italic>6 by PCR using the primers 5&#x02019;-aaaa<underline>ggatcc</underline>aatgcgcgttctggtggtgga-3&#x02019; and 5&#x02019;-tttt<underline>aagctt</underline>tcagatgcgatatccctcgc-3&#x02019; (underlines indicate the <italic>BamHI</italic> and <italic>HindIII</italic> sites, respectively). The amplified fragment was digested with <italic>BamHI</italic> plus <italic>HindIII</italic> and ligated into the <italic>BamHI</italic> and <italic>HindIII</italic> sites of pRSETB, yielding pRSET-Dbv6, which was introduced into BL21(DE3)pLysS cells by heat shock treatment<sup><xref ref-type="bibr" rid="CR40">40</xref></sup>. Plasmid pRSET-Dbv6 expresses the entire Dbv6 protein with a His6 tag at its N terminus under the control of the T7 promoter and the <italic>lac</italic> operator. Fidelity of PCR amplification was confirmed by DNA sequencing. Dbv6 overexpression and purification were performed using the procedures already described for Dbv4<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>.</p></sec><sec id="Sec16"><title>Gel mobility shift assay</title><p id="Par34">The gel mobility shift assay was performed according to the method already described<sup><xref ref-type="bibr" rid="CR41">41</xref></sup>. Briefly, for the binding assay, increasing amount of Dbv6 (2.8 to 14&#x02009;&#x000b5;g) was incubated for 10&#x02009;min at 4&#x02009;&#x000b0;C in 20&#x02009;&#x003bc;L of 12.5&#x02009;mM Tris-HCl (pH 7.5), 10% glycerol, 62.5&#x02009;mM KCl, 0.75&#x02009;mM DTT, and 5&#x02009;mM MgCl2. After 15&#x02009;min of incubation with 100&#x02009;ng of DNA, complexes and free DNA were resolved on non-denaturing 5% polyacrylamide gels run in 0.5&#x000d7; Tris-borate-EDTA buffer at 150&#x02009;V for approximately 2&#x02009;h and then stained in a bath containing ethidium bromide. The DNA probes were amplified by PCR using the primers listed in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>. BSA and the internal region of <italic>hrdB</italic> were used in control experiment (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">4</xref>).</p></sec><sec id="Sec17"><title>Phylogenetic analysis</title><p id="Par35">Thirteen response regulators and ten sensory kinases were retrieved from the MiBIG database of characterized actinobacterial biosynthetic gene clusters<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>; and forty-one response regulators and forty-seven sensory kinases were identified by blast searches of the <italic>N. gerenzanensis</italic> genome<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>. Seven characterized TCSs from <italic>S. coelicolor</italic> (AbsA, Afs, Dra, Glu, Osd, Pho and Van)<sup><xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR25">25</xref></sup> were also included. Sequences associated with <italic>N. gerenzanensis</italic> biosynthetic gene clusters were identified by AntiSMASH 5.0<sup><xref ref-type="bibr" rid="CR42">42</xref></sup>. Sequence alignments and phylogenetic analyses were performed with the MEGA 7 package<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>.</p></sec></sec><sec sec-type="supplementary-material"><title>Supplementary information</title><sec id="Sec18"><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41598_2020_63257_MOESM1_ESM.pdf"><caption><p>Supplementary Information.</p></caption></media></supplementary-material>
</p></sec></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><sec><title>Supplementary information</title><p>is available for this paper at 10.1038/s41598-020-63257-4.</p></sec><ack><title>Acknowledgements</title><p>The authors thank Marta Aronica, Letizia Lo Grasso and Andrea Sabella (University of Palermo, Dep. STEBICEF) for their laboratory assistance and Anna Maria Puglia for precious discussion.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>R.A. conceived, designed the work and wrote the manuscript. A.T. performed resistance assays and glycopeptide induction experiments, S.C. and C.F. performed transcriptional analysis and EMSA, P.C. performed protein analysis, M.S. carried out LC-MS analysis, S.D. performed bioinformatics analysis and wrote the manuscript. All authors contributed to the critical discussion of the manuscript, read and approved the final manuscript.</p></notes><notes notes-type="COI-statement"><title>Competing interests</title><p id="Par36">The authors declare no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="other">Alduina, R., Sosio, M. &#x00026; Donadio, S. Complex Regulatory Networks Governing Production of the Glycopeptide A40926. <italic>Antibiotics</italic><bold>7</bold>, 10.3390/antibiotics7020030 (2018).</mixed-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sosio</surname><given-names>M</given-names></name><name><surname>Canavesi</surname><given-names>A</given-names></name><name><surname>Stinchi</surname><given-names>S</given-names></name><name><surname>Donadio</surname><given-names>S</given-names></name></person-group><article-title>Improved production of A40926 by Nonomuraea sp. through deletion of a pathway-specific acetyltransferase</article-title><source>Applied microbiology and biotechnology</source><year>2010</year><volume>87</volume><fpage>1633</fpage><lpage>1638</lpage><pub-id pub-id-type="doi">10.1007/s00253-010-2579-2</pub-id><?supplied-pmid 20414653?><pub-id pub-id-type="pmid">20414653</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldstein</surname><given-names>BP</given-names></name><etal/></person-group><article-title>A40926, a new glycopeptide antibiotic with anti-Neisseria activity</article-title><source>Antimicrobial agents and chemotherapy</source><year>1987</year><volume>31</volume><fpage>1961</fpage><lpage>1966</lpage><pub-id pub-id-type="doi">10.1128/AAC.31.12.1961</pub-id><pub-id pub-id-type="pmid">2964225</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sosio</surname><given-names>M</given-names></name><name><surname>Stinchi</surname><given-names>S</given-names></name><name><surname>Beltrametti</surname><given-names>F</given-names></name><name><surname>Lazzarini</surname><given-names>A</given-names></name><name><surname>Donadio</surname><given-names>S</given-names></name></person-group><article-title>The gene cluster for the biosynthesis of the glycopeptide antibiotic A40926 by nonomuraea species</article-title><source>Chem Biol</source><year>2003</year><volume>10</volume><fpage>541</fpage><lpage>549</lpage><pub-id pub-id-type="doi">10.1016/S1074-5521(03)00120-0</pub-id><pub-id pub-id-type="pmid">12837387</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alduina</surname><given-names>R</given-names></name><etal/></person-group><article-title>Phosphate-controlled regulator for the biosynthesis of the dalbavancin precursor A40926</article-title><source>Journal of bacteriology</source><year>2007</year><volume>189</volume><fpage>8120</fpage><lpage>8129</lpage><pub-id pub-id-type="doi">10.1128/JB.01247-07</pub-id><?supplied-pmid 17873036?><pub-id pub-id-type="pmid">17873036</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lo Grasso</surname><given-names>L</given-names></name><etal/></person-group><article-title>Two Master Switch Regulators Trigger A40926 Biosynthesis in Nonomuraea sp. Strain ATCC 39727</article-title><source>Journal of bacteriology</source><year>2015</year><volume>197</volume><fpage>2536</fpage><lpage>2544</lpage><pub-id pub-id-type="doi">10.1128/JB.00262-15</pub-id><?supplied-pmid 25986904?><pub-id pub-id-type="pmid">25986904</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donadio</surname><given-names>S</given-names></name><name><surname>Sosio</surname><given-names>M</given-names></name><name><surname>Stegmann</surname><given-names>E</given-names></name><name><surname>Weber</surname><given-names>T</given-names></name><name><surname>Wohlleben</surname><given-names>W</given-names></name></person-group><article-title>Comparative analysis and insights into the evolution of gene clusters for glycopeptide antibiotic biosynthesis</article-title><source>Molecular genetics and genomics: MGG</source><year>2005</year><volume>274</volume><fpage>40</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1007/s00438-005-1156-3</pub-id><?supplied-pmid 16007453?><pub-id pub-id-type="pmid">16007453</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>HJ</given-names></name><etal/></person-group><article-title>Characterization of an inducible vancomycin resistance system in Streptomyces coelicolor reveals a novel gene (vanK) required for drug resistance</article-title><source>Molecular microbiology</source><year>2004</year><volume>52</volume><fpage>1107</fpage><lpage>1121</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2004.04032.x</pub-id><?supplied-pmid 15130128?><pub-id pub-id-type="pmid">15130128</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutchings</surname><given-names>MI</given-names></name><name><surname>Hong</surname><given-names>HJ</given-names></name><name><surname>Buttner</surname><given-names>MJ</given-names></name></person-group><article-title>The vancomycin resistance VanRS two-component signal transduction system of Streptomyces coelicolor</article-title><source>Molecular microbiology</source><year>2006</year><volume>59</volume><fpage>923</fpage><lpage>935</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2005.04953.x</pub-id><?supplied-pmid 16420361?><pub-id pub-id-type="pmid">16420361</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>HJ</given-names></name><name><surname>Hutchings</surname><given-names>MI</given-names></name><name><surname>Buttner</surname><given-names>MJ</given-names></name></person-group><article-title>Biotechnology &#x00026; Biological Sciences Research Council, U. K. Vancomycin resistance VanS/VanR two-component systems</article-title><source>Advances in experimental medicine and biology</source><year>2008</year><volume>631</volume><fpage>200</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1007/978-0-387-78885-2_14</pub-id><?supplied-pmid 18792691?><pub-id pub-id-type="pmid">18792691</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novotna</surname><given-names>GB</given-names></name><name><surname>Kwun</surname><given-names>MJ</given-names></name><name><surname>Hong</surname><given-names>HJ</given-names></name></person-group><article-title><italic>In Vivo</italic> Characterization of the Activation and Interaction of the VanR-VanS Two-Component Regulatory System Controlling Glycopeptide Antibiotic Resistance in Two Related Streptomyces Species</article-title><source>Antimicrobial agents and chemotherapy</source><year>2015</year><volume>60</volume><fpage>1627</fpage><lpage>1637</lpage><pub-id pub-id-type="doi">10.1128/AAC.01367-15</pub-id><?supplied-pmid 26711760?><pub-id pub-id-type="pmid">26711760</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haldimann</surname><given-names>A</given-names></name><name><surname>Fisher</surname><given-names>SL</given-names></name><name><surname>Daniels</surname><given-names>LL</given-names></name><name><surname>Walsh</surname><given-names>CT</given-names></name><name><surname>Wanner</surname><given-names>BL</given-names></name></person-group><article-title>Transcriptional regulation of the Enterococcus faecium BM4147 vancomycin resistance gene cluster by the VanS-VanR two-component regulatory system in Escherichia coli K-12</article-title><source>Journal of bacteriology</source><year>1997</year><volume>179</volume><fpage>5903</fpage><lpage>5913</lpage><pub-id pub-id-type="doi">10.1128/jb.179.18.5903-5913.1997</pub-id><?supplied-pmid 9294451?><pub-id pub-id-type="pmid">9294451</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arthur</surname><given-names>M</given-names></name><name><surname>Molinas</surname><given-names>C</given-names></name><name><surname>Courvalin</surname><given-names>P</given-names></name></person-group><article-title>The VanS-VanR two-component regulatory system controls synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147</article-title><source>Journal of bacteriology</source><year>1992</year><volume>174</volume><fpage>2582</fpage><lpage>2591</lpage><pub-id pub-id-type="doi">10.1128/jb.174.8.2582-2591.1992</pub-id><?supplied-pmid 1556077?><pub-id pub-id-type="pmid">1556077</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sosio</surname><given-names>M</given-names></name><etal/></person-group><article-title>Organization of the teicoplanin gene cluster in Actinoplanes teichomyceticus</article-title><source>Microbiology</source><year>2004</year><volume>150</volume><fpage>95</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1099/mic.0.26507-0</pub-id><?supplied-pmid 14702401?><pub-id pub-id-type="pmid">14702401</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>TL</given-names></name><etal/></person-group><article-title>Biosynthetic gene cluster of the glycopeptide antibiotic teicoplanin: characterization of two glycosyltransferases and the key acyltransferase</article-title><source>Chem Biol</source><year>2004</year><volume>11</volume><fpage>107</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2004.01.001</pub-id><?supplied-pmid 15113000?><pub-id pub-id-type="pmid">15113000</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pootoolal</surname><given-names>J</given-names></name><etal/></person-group><article-title>Assembling the glycopeptide antibiotic scaffold: The biosynthesis of A47934 from Streptomyces toyocaensis NRRL15009</article-title><source>Proc Natl Acad Sci USA</source><year>2002</year><volume>99</volume><fpage>8962</fpage><lpage>8967</lpage><pub-id pub-id-type="doi">10.1073/pnas.102285099</pub-id><?supplied-pmid 12060705?><pub-id pub-id-type="pmid">12060705</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaberle</surname><given-names>TF</given-names></name><etal/></person-group><article-title>Self-resistance and cell wall composition in the glycopeptide producer Amycolatopsis balhimycina</article-title><source>Antimicrobial agents and chemotherapy</source><year>2011</year><volume>55</volume><fpage>4283</fpage><lpage>4289</lpage><pub-id pub-id-type="doi">10.1128/AAC.01372-10</pub-id><?supplied-pmid 21690280?><pub-id pub-id-type="pmid">21690280</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x02019;Argenio</surname><given-names>V</given-names></name><etal/></person-group><article-title>The complete 12 Mb genome and transcriptome of Nonomuraea gerenzanensis with new insights into its duplicated &#x0201c;magic&#x0201d; RNA polymerase</article-title><source>Scientific reports</source><year>2016</year><volume>6</volume><fpage>18</fpage><pub-id pub-id-type="doi">10.1038/s41598-016-0025-0</pub-id><?supplied-pmid 28442708?><pub-id pub-id-type="pmid">28442708</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marcone</surname><given-names>GL</given-names></name><etal/></person-group><article-title>Novel mechanism of glycopeptide resistance in the A40926 producer Nonomuraea sp. ATCC 39727</article-title><source>Antimicrobial agents and chemotherapy</source><year>2010</year><volume>54</volume><fpage>2465</fpage><lpage>2472</lpage><pub-id pub-id-type="doi">10.1128/AAC.00106-10</pub-id><?supplied-pmid 20308385?><pub-id pub-id-type="pmid">20308385</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Binda</surname><given-names>E</given-names></name><name><surname>Marcone</surname><given-names>GL</given-names></name><name><surname>Pollegioni</surname><given-names>L</given-names></name><name><surname>Marinelli</surname><given-names>F</given-names></name></person-group><article-title>Characterization of VanYn, a novel D,D-peptidase/D,D-carboxypeptidase involved in glycopeptide antibiotic resistance in Nonomuraea sp. ATCC 39727</article-title><source>The FEBS journal</source><year>2012</year><volume>279</volume><fpage>3203</fpage><lpage>3213</lpage><pub-id pub-id-type="doi">10.1111/j.1742-4658.2012.08706.x</pub-id><?supplied-pmid 22788848?><pub-id pub-id-type="pmid">22788848</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sosio</surname><given-names>M</given-names></name><name><surname>Bossi</surname><given-names>E</given-names></name><name><surname>Bianchi</surname><given-names>A</given-names></name><name><surname>Donadio</surname><given-names>S</given-names></name></person-group><article-title>Multiple peptide synthetase gene clusters in Actinomycetes</article-title><source>Molecular &#x00026; general genetics: MGG</source><year>2000</year><volume>264</volume><fpage>213</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1007/s004380000336</pub-id><pub-id pub-id-type="pmid">11085259</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yushchuk</surname><given-names>O</given-names></name><etal/></person-group><article-title>Regulation of teicoplanin biosynthesis: refining the roles of tei cluster-situated regulatory genes</article-title><source>Applied microbiology and biotechnology</source><year>2019</year><volume>103</volume><fpage>4089</fpage><lpage>4102</lpage><pub-id pub-id-type="doi">10.1007/s00253-019-09789-w</pub-id><?supplied-pmid 30937499?><pub-id pub-id-type="pmid">30937499</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medema</surname><given-names>MH</given-names></name><etal/></person-group><article-title>Minimum Information about a Biosynthetic Gene cluster</article-title><source>Nat Chem Biol</source><year>2015</year><volume>11</volume><fpage>625</fpage><lpage>631</lpage><pub-id pub-id-type="doi">10.1038/nchembio.1890</pub-id><?supplied-pmid 26284661?><pub-id pub-id-type="pmid">26284661</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Heul</surname><given-names>HU</given-names></name><name><surname>Bilyk</surname><given-names>BL</given-names></name><name><surname>McDowall</surname><given-names>KJ</given-names></name><name><surname>Seipke</surname><given-names>RF</given-names></name><name><surname>van Wezel</surname><given-names>GP</given-names></name></person-group><article-title>Regulation of antibiotic production in Actinobacteria: new perspectives from the post-genomic era</article-title><source>Natural product reports</source><year>2018</year><volume>35</volume><fpage>575</fpage><lpage>604</lpage><pub-id pub-id-type="doi">10.1039/c8np00012c</pub-id><?supplied-pmid 29721572?><pub-id pub-id-type="pmid">29721572</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daniel-Ivad</surname><given-names>M</given-names></name><name><surname>Pimentel-Elardo</surname><given-names>S</given-names></name><name><surname>Nodwell</surname><given-names>JR</given-names></name></person-group><article-title>Control of Specialized Metabolism by Signaling and Transcriptional Regulation: Opportunities for New Platforms for Drug Discovery?</article-title><source>Annual review of microbiology</source><year>2018</year><volume>72</volume><fpage>25</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1146/annurev-micro-022618-042458</pub-id><?supplied-pmid 29799791?><pub-id pub-id-type="pmid">29799791</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nazari</surname><given-names>B</given-names></name><etal/></person-group><article-title>Nonomuraea sp. ATCC 55076 harbours the largest actinomycete chromosome to date and the kistamicin biosynthetic gene cluster</article-title><source>MedChemComm</source><year>2017</year><volume>8</volume><fpage>780</fpage><lpage>788</lpage><pub-id pub-id-type="doi">10.1039/c6md00637j</pub-id><?supplied-pmid 28626548?><pub-id pub-id-type="pmid">28626548</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonsior</surname><given-names>M</given-names></name><etal/></person-group><article-title>Biosynthesis of the Peptide Antibiotic Feglymycin by a Linear Nonribosomal Peptide Synthetase Mechanism</article-title><source>Chembiochem: a European journal of chemical biology</source><year>2015</year><volume>16</volume><fpage>2610</fpage><lpage>2614</lpage><pub-id pub-id-type="doi">10.1002/cbic.201500432</pub-id><?supplied-pmid 26515424?><pub-id pub-id-type="pmid">26515424</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naruse</surname><given-names>N</given-names></name><name><surname>Oka</surname><given-names>M</given-names></name><name><surname>Konishi</surname><given-names>M</given-names></name><name><surname>Oki</surname><given-names>T</given-names></name></person-group><article-title>New antiviral antibiotics, kistamicins A and B. II. Structure determination</article-title><source>The Journal of antibiotics</source><year>1993</year><volume>46</volume><fpage>1812</fpage><lpage>1818</lpage><pub-id pub-id-type="doi">10.7164/antibiotics.46.1812</pub-id><?supplied-pmid 8294238?><pub-id pub-id-type="pmid">8294238</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naruse</surname><given-names>N</given-names></name><etal/></person-group><article-title>New antiviral antibiotics, kistamicins A and B. I. Taxonomy, production, isolation, physico-chemical properties and biological activities</article-title><source>The Journal of antibiotics</source><year>1993</year><volume>46</volume><fpage>1804</fpage><lpage>1811</lpage><pub-id pub-id-type="doi">10.7164/antibiotics.46.1804</pub-id><?supplied-pmid 8294237?><pub-id pub-id-type="pmid">8294237</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vertesy</surname><given-names>L</given-names></name><etal/></person-group><article-title>Feglymycin, a novel inhibitor of the replication of the human immunodeficiency virus. Fermentation, isolation and structure elucidation</article-title><source>The Journal of antibiotics</source><year>1999</year><volume>52</volume><fpage>374</fpage><lpage>382</lpage><pub-id pub-id-type="doi">10.7164/antibiotics.52.374</pub-id><?supplied-pmid 10395273?><pub-id pub-id-type="pmid">10395273</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kilian</surname><given-names>R</given-names></name><name><surname>Frasch</surname><given-names>HJ</given-names></name><name><surname>Kulik</surname><given-names>A</given-names></name><name><surname>Wohlleben</surname><given-names>W</given-names></name><name><surname>Stegmann</surname><given-names>E</given-names></name></person-group><article-title>The VanRS Homologous Two-Component System VnlRSAb of the Glycopeptide Producer Amycolatopsis balhimycina Activates Transcription of the vanHAXSc Genes in Streptomyces coelicolor, but not in A. balhimycina</article-title><source>Microbial drug resistance</source><year>2016</year><volume>22</volume><fpage>499</fpage><lpage>509</lpage><pub-id pub-id-type="doi">10.1089/mdr.2016.0128</pub-id><?supplied-pmid 27420548?><pub-id pub-id-type="pmid">27420548</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foulston</surname><given-names>L</given-names></name><name><surname>Bibb</surname><given-names>M</given-names></name></person-group><article-title>Feed-forward regulation of microbisporicin biosynthesis in Microbispora corallina</article-title><source>Journal of bacteriology</source><year>2011</year><volume>193</volume><fpage>3064</fpage><lpage>3071</lpage><pub-id pub-id-type="doi">10.1128/JB.00250-11</pub-id><?supplied-pmid 21478362?><pub-id pub-id-type="pmid">21478362</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stegmann</surname><given-names>E</given-names></name><name><surname>Frasch</surname><given-names>HJ</given-names></name><name><surname>Kilian</surname><given-names>R</given-names></name><name><surname>Pozzi</surname><given-names>R</given-names></name></person-group><article-title>Self-resistance mechanisms of actinomycetes producing lipid II-targeting antibiotics</article-title><source>International journal of medical microbiology: IJMM</source><year>2015</year><volume>305</volume><fpage>190</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1016/j.ijmm.2014.12.015</pub-id><?supplied-pmid 25601631?><pub-id pub-id-type="pmid">25601631</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alduina</surname><given-names>R</given-names></name><etal/></person-group><article-title>Expression in Streptomyces lividans of Nonomuraea genes cloned in an artificial chromosome</article-title><source>Applied microbiology and biotechnology</source><year>2005</year><volume>68</volume><fpage>656</fpage><lpage>662</lpage><pub-id pub-id-type="doi">10.1007/s00253-005-1929-y</pub-id><?supplied-pmid 15821915?><pub-id pub-id-type="pmid">15821915</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giardina</surname><given-names>A</given-names></name><etal/></person-group><article-title>Two heterologously expressed Planobispora rosea proteins cooperatively induce Streptomyces lividans thiostrepton uptake and storage from the extracellular medium</article-title><source>Microbial cell factories</source><year>2010</year><volume>9</volume><fpage>44</fpage><pub-id pub-id-type="doi">10.1186/1475-2859-9-44</pub-id><?supplied-pmid 20534129?><pub-id pub-id-type="pmid">20534129</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alt</surname><given-names>S</given-names></name><etal/></person-group><article-title>Toward Single-Peak Dalbavancin Analogs through Biology and Chemistry</article-title><source>ACS Chem Biol</source><year>2019</year><volume>14</volume><fpage>356</fpage><lpage>360</lpage><pub-id pub-id-type="doi">10.1021/acschembio.9b00050</pub-id><?supplied-pmid 30830742?><pub-id pub-id-type="pmid">30830742</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gust</surname><given-names>B</given-names></name><name><surname>Challis</surname><given-names>GL</given-names></name><name><surname>Fowler</surname><given-names>K</given-names></name><name><surname>Kieser</surname><given-names>T</given-names></name><name><surname>Chater</surname><given-names>KF</given-names></name></person-group><article-title>PCR-targeted Streptomyces gene replacement identifies a protein domain needed for biosynthesis of the sesquiterpene soil odor geosmin</article-title><source>Proc Natl Acad Sci USA</source><year>2003</year><volume>100</volume><fpage>1541</fpage><lpage>1546</lpage><pub-id pub-id-type="doi">10.1073/pnas.0337542100</pub-id><?supplied-pmid 12563033?><pub-id pub-id-type="pmid">12563033</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donadio</surname><given-names>S</given-names></name><name><surname>Monciardini</surname><given-names>P</given-names></name><name><surname>Sosio</surname><given-names>M</given-names></name></person-group><article-title>Chapter 1. Approaches to discovering novel antibacterial and antifungal agents</article-title><source>Methods in enzymology</source><year>2009</year><volume>458</volume><fpage>3</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1016/S0076-6879(09)04801-0</pub-id><?supplied-pmid 19374977?><pub-id pub-id-type="pmid">19374977</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez-Quinonez</surname><given-names>N</given-names></name><etal/></person-group><article-title>New PhiBT1 site-specific integrative vectors with neutral phenotype in Streptomyces</article-title><source>Applied microbiology and biotechnology</source><year>2016</year><volume>100</volume><fpage>2797</fpage><lpage>2808</lpage><pub-id pub-id-type="doi">10.1007/s00253-015-7271-0</pub-id><?supplied-pmid 26758297?><pub-id pub-id-type="pmid">26758297</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russo</surname><given-names>M</given-names></name><etal/></person-group><article-title>Binding abilities of polyaminocyclodextrins: polarimetric investigations and biological assays</article-title><source>Beilstein journal of organic chemistry</source><year>2017</year><volume>13</volume><fpage>2751</fpage><lpage>2763</lpage><pub-id pub-id-type="doi">10.3762/bjoc.13.271</pub-id><?supplied-pmid 29564010?><pub-id pub-id-type="pmid">29564010</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubino</surname><given-names>S</given-names></name><etal/></person-group><article-title>Synthesis, structural characterization, anti-proliferative and antimicrobial activity of binuclear and mononuclear Pt(II) complexes with perfluoroalkyl-heterocyclic ligands</article-title><source>Inorg Chim Acta</source><year>2018</year><volume>483</volume><fpage>180</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1016/j.ica.2018.07.039</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blin</surname><given-names>K</given-names></name><etal/></person-group><article-title>antiSMASH 5.0: updates to the secondary metabolite genome mining pipeline</article-title><source>Nucleic acids research</source><year>2019</year><volume>47</volume><fpage>W81</fpage><lpage>W87</lpage><pub-id pub-id-type="doi">10.1093/nar/gkz310</pub-id><?supplied-pmid 31032519?><pub-id pub-id-type="pmid">31032519</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Stecher</surname><given-names>G</given-names></name><name><surname>Tamura</surname><given-names>K</given-names></name></person-group><article-title>MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets</article-title><source>Molecular biology and evolution</source><year>2016</year><volume>33</volume><fpage>1870</fpage><lpage>1874</lpage><pub-id pub-id-type="doi">10.1093/molbev/msw054</pub-id><?supplied-pmid 27004904?><pub-id pub-id-type="pmid">27004904</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacNeil</surname><given-names>DJ</given-names></name><etal/></person-group><article-title>Analysis of Streptomyces avermitilis genes required for avermectin biosynthesis utilizing a novel integration vector</article-title><source>Gene</source><year>1992</year><volume>111</volume><fpage>61</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1016/0378-1119(92)90603-m</pub-id><?supplied-pmid 1547955?><pub-id pub-id-type="pmid">1547955</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Datsenko</surname><given-names>KA</given-names></name><name><surname>Wanner</surname><given-names>BL</given-names></name></person-group><article-title>One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products</article-title><source>Proc Natl Acad Sci USA</source><year>2000</year><volume>97</volume><fpage>6640</fpage><lpage>6645</lpage><pub-id pub-id-type="doi">10.1073/pnas.120163297</pub-id><?supplied-pmid 10829079?><pub-id pub-id-type="pmid">10829079</pub-id></element-citation></ref></ref-list></back></article>